Anti-inflammatory peptides

Details Anti-inflammatory peptides Anti-inflammatory peptides

2006-12-26

2006-12-26

Tsang, Cecilia J. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S019300, C530S300000, C530S331000

Reexamination Certificate

active

07153835

ABSTRACT:
Methods for inhibiting an inflammatory reaction in a mammal and pharmaceutical compositions are provided. The methods comprise administering to the mammal an effective amount of a peptide of the formula:X1-X2-X3wherein X1is selected from the group consisting of 2-amino-hexanoic acid; 2-amino-heptanoic acid; 2-amino-octanoic acid; cyclohexyl-substituted 2-amino-ethanoic acid, 2-amino-propanoic acid or 2-amino-butanoic acid and methionine; X2is an acidic amino acid; and X3is an aliphatic amino acid; or of a peptide of the formula: X4-X5wherein X4is an aromatic or aliphatic amino acid; and X5is an acidic amino acid.

REFERENCES:
patent: 4012367 (1977-03-01), Mazur
patent: 4880779 (1989-11-01), Gallaher
patent: 5635593 (1997-06-01), Cheronis et al.
patent: 5837686 (1998-11-01), Kirby et al.
patent: 6117840 (2000-09-01), Arrhenius et al.
patent: 6586403 (2003-07-01), Mathison et al.
patent: 6852697 (2005-02-01), Mathison et al.
patent: 9806742 (1998-02-01), None
patent: 0063233 (2000-10-01), None
J.M. Lee, et al. J. Neuropathol. Exp. Neurol. (2002) 61(2), pp. 125-131.
Befus, D. et al., Cervical Sympathetic Nerve Trunk-Submandibular Gland Axis: Neural Control of Anti-inflammatory Peptides that Modulate Airways Inflammation (2000), Canadian Network for Neuroimmune Biology Symposium, Winnipeg, Manitoba, Jun. 9-12, 2000.
Befus, D. et al., C-terminal Peptides of the Prohormone SMR1 Inhibit Allergic Information in the Airways (2000), CSI 2000, Quebec, Canada.
Befus, D. et al., Inhibition of Allergic Inflammation C-terminal Peptides of SMR1 (2000), CIA, Japan.
Davison, J.S. et al., Salivary Gland Peptides: Their role in Anaphylaxis and LPS-induced Inflammation, (2000), CANIB Symposium, Manitoba, Jun. 9-12, 2000.
Déry, R. et al., A Novel Peptide Isolated from Prohormone Smr1 Inhibits Allergic Inflammation of the Airways (2000), American Thoracic Society, Toronto, Canada, May 5-10, 2000.
Déry, R. et al., Inhibition Of Airway Inflammation by feG: A C-Terminal Peptide Isolated from Rat Submandibular Gland Prohormone Smr1 (1999), Alberta Respiratory Disease Symposium, Banff, Alberta, Oct. 22-24, 1999.
Hwang, S. et al., Inhibition of Gene Expression in Human Cells Through Small Molecule-RNA Interactions (1999), PNAS, v. 96, pp. 12997-13002.
Llinas—Brunet et al., (1999), J. Med.Chem., v.42, pp. 722-729.
Mathison R: The Submandibular Glands: a role in homeostasis and allostasis. (1995), Biomedical Reviews, v. 4, pp. 61-69.
Mathison RD. et al., . Reduction in cardiovascular anaphylaxis by submandibular gland peptide-T (1995), Proc. West. Pharmacol. Soc., v. 40, pp. 73-74.
Mathison, R. et al., A Novel Submandibular Gland Peptide Protects Against Endotoxic and Anaphylactic Shock (1997), Am. J. Physiol., v. 273: R1017-R1023.
Mathison, R. et al., Attenuation of Intestinal and Cardiovascular Anaphylaxis by the Salivary Gland Tripeptide FEG and Its D-Isomeric Analog feG (1998), Peptides, v. 19, pp. 1037-1042.
Mathison, R. et al., Inhibition of Leucocyte Rolling by Submandibular Gland Peptide-T (CGPT),(1999) Proc. West. Pharmacol. Soc., v. 42, pp. 39-40.
Mathison, R. et al., Neuroendocrine Regulation of Inflammation and Tissue Repair by Submandibular Gland Factors (1994), Immunology Today, v. 15, p. 527.
Mathison, R. et al., Reduction of endotoxin-induced leukocyte activation in the rat intestine by a D-isomeric analogue of salivary gland tripeptide FEG. (2000), Abstract: American Gastroenterology Association, San Diego, California, May 21-24, 2000.
Mathison, R. et al., Removal of the Submandibular Glands Increase the Acute Hypotensive Response to Endotoxin (1993), Circ. Shock, v. 39, p. 52.
Mathison, R. et al., Submandibular Gland Peptide-T (SGP-T) : Modulation of Endotoxic and Anaphylactic Shock, (1997), Drug Devel. Res., v. 42, pp. 164-171.
Mathison, R. et al., Submandibular Gland Peptide-T (SGP-T) Inhibits Intestinal Anaphylaxis (1997), Dig. Dis. Sci., v. 42, pp. 2378-2383.
Mathison, R. et al., The D-isomeric Analog of Salivary Gland Tripeptide FEG Reduces Endotoxin Induced Cell Activation in the Rat Intestine (1999), Falk Symposium: Neurogastroenterology—From the Basics to the Clinics, Jun. 21-22, 1999.
Mathison, R. et al., The Role of Submandibular Gland Peptide feG in Anaphylaxis-Induced Cardiac Inflammation (2000), Shock, v. 13 (Suppl.): 52.
Munch, G. et al., Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library (1999), Nature Biotech., v. 17, pp. 1006-1010.
Nkemdirim M. et al., Modulation of neutrophil activity by submandibular gland peptide-T (SGP-T). (1998), Pol. J. Pharmacol. v. 50: 417-424.
Ramaswamy K. et al., Marked Antiinflammatory Effects of Decentralization of the Superior Cervical Ganglia (1990), J. Exp. Med., v. 172, pp. 1819-1830.
Schullek, J. R. et al., A High-Density Screening Format for Encoded Combinatorial Libraries: Assay Miniaturization and Its Application to Enzymatic Reactions (1997), Anal. Biochem., v. 246, pp. 20-29.
Slootstra, Structural aspects of antibody-antigen interaction revealed through small random peptide libraries (1996), Molecular Diversity, v. 1, pp. 87-96.
Turesin, F. et al., The Role of Submandibular Gland Peptide feG in Anaphylaxis-Induced Cardiac Inflammation (2000), Shock, v. 13 (Suppl.): 52.
Dery, R.E., et al., Inhibition of Allergic Inflammation by C-Terminal Peptides of the Prohormone Submandibular Rat 1 (SMR-1), (2001), Int. Arch. Allergy Immunol., v. 124, pp. 201-204.
Grossmann, C. et al., Partitioning of Low Molecular Combination Peptides in Aqueous Two-Phase Systems of Poly(ethylene glycol).and Dextran in the Presence of Small Amounts of K2HPO4/KH2PO4Buffer at 293: experimental results, (1998), Biotechnology and Bioengineering, v. 60, No. 6, pp. 699-711.
Liakopoulou-Kyriakides, M. et al., Effect of Leu-(ASP, ASN, GLU, GLN) Dipeptides on Platelet Aggregationin vitro(1990), Biochemistry International, v. 22, No. 4, pp. 617-625.
Mathison, R. et al., Attenuation of Intestinal and Cardiovascular Anaphylaxis by the Salivary Gland Tripeptide FEG and its D-isomeric Analog feG, (1998), Peptides, v. 19, No. 6, pp. 1037-1042.
Metwally, E. et al., Submandibular Gland Tripeptide FEG (Phe-Glu-Gly) and Analogues: keys to structure Determination , (2002), Peptides, v. 23, pp. 193-199.
Schon, I. et al., Pentagastrin Analogs Containing α-aminooxy Acids, II, (1978), Hoppe-Seyler's Z. Physiol. Chem. Bd. 359, pp. 897-916.
Tan, D. et al., The Carboxamide feG(NH2) Inhibits Endotoxin Perturbation of Intestinal Motility, (2000), European Journal of Pharmacology v. 409, pp. 203-205.

Affiliated with

Also associated with

Rating

Anti-inflammatory peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-inflammatory peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3713266